These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18461358

  • 1. Autoimmune thyroiditis in a child with steroid-dependent nephrotic syndrome.
    Tasic V, Angjeleska M, Ristoska-Bojkovska N, Petrusevska G, Gucev Z.
    Eur J Pediatr; 2009 Feb; 168(2):229-31. PubMed ID: 18461358
    [Abstract] [Full Text] [Related]

  • 2. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [Abstract] [Full Text] [Related]

  • 3. Autoimmune thyroiditis and vitiligo in a child with minimal change nephrotic syndrome.
    Kuzmanovska DB, Shahpazova EM, Kocova MJ, Gruevska SJ, Petrushevska G.
    Pediatr Nephrol; 2001 Dec; 16(12):1137-8. PubMed ID: 11793116
    [Abstract] [Full Text] [Related]

  • 4. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
    Tenbrock K, Müller-Berghaus J, Fuchshuber A, Michalk D, Querfeld U.
    Pediatr Nephrol; 1998 Aug; 12(6):459-62. PubMed ID: 9745868
    [Abstract] [Full Text] [Related]

  • 5. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 6. [Simultaneous corticosteroid-sensitive nephrotic syndrome and Hashimoto's thyroiditis].
    Aleixandre Blanquer F, Navarro Navarro C, Velasco García R, Jover Cerdá J.
    An Pediatr (Barc); 2004 Aug; 61(2):191-2. PubMed ID: 15274892
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J, Kryński J.
    Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
    [Abstract] [Full Text] [Related]

  • 8. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K, Grisaru S, Stephens D, Arbus G.
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [Abstract] [Full Text] [Related]

  • 10. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
    Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
    [Abstract] [Full Text] [Related]

  • 11. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC, all members of the Levamisole Study Group.
    Kidney Int; 2018 Feb 27; 93(2):510-518. PubMed ID: 29054532
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN, Hotchandani HM, Zubair AM, Lohana NC, Veerwani NR.
    BMC Nephrol; 2019 Jul 03; 20(1):239. PubMed ID: 31269922
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of two unconventional agents in steroid-dependent nephrotic children.
    Donia AF, Ammar HM, El-Agroudy Ael-B, Moustafa Fel-H, Sobh MA.
    Pediatr Nephrol; 2005 Oct 03; 20(10):1420-5. PubMed ID: 16047223
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of levamisole in the treatment of primary nephrosis in children.
    Mongeau JG, Robitaille PO, Roy F.
    Pediatr Nephrol; 1988 Oct 03; 2(4):398-401. PubMed ID: 3153050
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic trial with levamisole in children with idiopathic minimal change nephrotic syndrome].
    Urdaneta Carruyo E, Zúñiga Armendariz V, Gordillo Paniagua G.
    Bol Med Hosp Infant Mex; 1983 Feb 03; 40(2):82-8. PubMed ID: 6344884
    [No Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide in treatment of minimal change nephrotic syndrome.
    Shohet I, Meyerovitch J, Aladjem M, Boichis H.
    Eur J Pediatr; 1988 Apr 03; 147(3):239-41. PubMed ID: 3391218
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S.
    Indian Pediatr; 2014 May 03; 51(5):371-3. PubMed ID: 24953577
    [Abstract] [Full Text] [Related]

  • 18. Management of Adult Minimal Change Disease.
    Korbet SM, Whittier WL.
    Clin J Am Soc Nephrol; 2019 Jun 07; 14(6):911-913. PubMed ID: 30952629
    [No Abstract] [Full Text] [Related]

  • 19. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO, Kari JA.
    Saudi Med J; 2002 Sep 07; 23(9):1101-4. PubMed ID: 12370722
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
    Pediatr Nephrol; 2019 Nov 07; 34(11):2417-2421. PubMed ID: 31435725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.